Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler-Reference-Cited by-同舟云学术

Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler

Published:2015-12 Issue:6 Volume:28 Page:486-497
ISSN:1941-2711
Container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery
language:en
Short-container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery

Author:

Prime David¹,de Backer Wilfried²,Hamilton Melanie¹,Cahn Anthony³,Preece Andrew⁴,Kelleher Dennis⁵,Baines Amanda³,Moore Alison⁴,Brealey Noushin⁴,Moynihan Jackie⁶

Affiliation:

1. GSK Research and Development Ltd., Ware, Hertfordshire, United Kingdom.

2. Department of Pulmonary Medicine, University Hospital and University of Antwerp, Belgium.

3. Medicines Discovery and Development, GSK, Stevenage, Hertfordshire, United Kingdom.

4. Respiratory Therapy Area Unit, GSK, Stockley Park West, Middlesex, United Kingdom.

5. GSK, Research Triangle Park, Durham, North Carolina, USA.

6. Synergy Clinical, Langley, Berks, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmaceutical Science,Pulmonary and Respiratory Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/jamp.2015.1224

Reference24 articles.

1. Aerosol Devices and Asthma Therapy

2. Guidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy

3. Inhaler Devices for Patients with COPD

4. General factors influencing drug delivery to the lung

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and Factors Affecting the Optimal and Non-optimal Peak Inspiratory Flow Rate in Stable and Exacerbation Phases of Chronic Obstructive Pulmonary Disease and Bronchial Asthma in India;Cureus;2024-04-21

2. Comparative study of the inhalation parameters of COPD patients through NEXThaler® and Ellipta® dry powder inhalers;Respiratory Medicine;2024-04

3. The role of peak inspiratory flow in the selection of inhalation therapy in patients with chronic obstructive pulmonary disease;Meditsinskiy sovet = Medical Council;2023-11-16

4. Development of a Smart Metered-Dose Inhaler for Asthma Based on Computational Fluid Dynamics;Symmetry;2023-09-07

5. Evaluating dry powder inhalers: From in vitro studies to mobile health technologies;Respiratory Medicine;2023-08